Title : Prognostic and predictive value of extended RAS mutation and mismatch repair status in stage III colorectal cancer.

Pub. Date : 2016 Jul

PMID : 27089049






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Extended RAS (KRAS/NRAS) mutations are proposed as predictive indicators with respect to the efficacy of adjuvant UFT chemotherapy in patients with resected stage III colorectal cancer. Tegafur KRAS proto-oncogene, GTPase Homo sapiens